Open Access<p>Trends in Real-World Neovascular AMD Treatment Outcomes in the UK</p>
Author(s) -
Hemal Mehta,
Leah Kim,
Thibaud Mathis,
Pardis Zalmay,
Faruque Ghanchi,
Winfried Amoaku,
Laurent Kodjikian
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s275977
Subject(s) - medicine , aflibercept , macular degeneration , ranibizumab , visual acuity , impact factor , ophthalmology , medline , clinical trial , family medicine , bevacizumab , optometry , political science , chemotherapy , law
To report trends in real-world outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD) in the United Kingdom (UK) over the last decade.